Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Ben Theurer

Barclays · covers Consumer Defensive, Basic Materials

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).

Questions
61on tracked calls
Challenge rate
13%8 of 61 questions
Companies
7questioned at least once
Reporting periods
9with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 61 of 61 questions from 7 companies

TSNTyson Foods15 questions · 8 reporting periods · 2 of 15 challenging
TSN company page →

Calendar 2026 Q2

what would take you to the higher end of the guidance versus what would be basically a year-over-year fourth quarter flat

Guidance ReliabilityMarginTranscript · FY2026 Q3 →
Show response

King said last year's Q4 was an all-time record they won't repeat; Calaway framed the maintained chicken range as a balanced roughly 48-52 front/back-half split.

how confident are you as it looks into next year to maintain that margin level in prepared foods in particular?

MarginCost PressureTranscript · FY2026 Q3 →
Show response

King credited innovation, distribution, and strategic customer partnerships; Calaway pointed to a more balanced Q4 and continued volume and profit growth into 2027.

Calendar 2026 Q1

how sustainable the performance here is and what role genetics played in most recent months

Competitive DynamicsInnovation & R&DTranscript · FY2026 Q2 →
Show response

King addressed sustainability directly, attributing the $112M YoY Chicken beat to mix, strategic customers, and genetics, and ruled out one-time Koch fire volume.

Calendar 2025 Q4

where you are in the journey of price increases of some of the food of the input cost inflation that you've been facing, particularly from beef that goes into prepared foods

PricingCost PressureTranscript · FY2026 Q1 →
Show response

Donnie explained 8% net sales increase was not pure price but a combination of channel mix and formula-based pass-through pricing; beef and pork trim remains elevated but other inputs stabilizing; fifth consecutive quarter of sequential improvement in Prepared Foods.

the rationale behind that and, like, the management incentives on a per business level. And if there's any relationship from that into what the free cash flow change is

Guidance ReliabilityCapital AllocationTranscript · FY2026 Q1 →
Show response

Donnie explained the change from AOI to SOI was intentional to remove ~$1 billion in annual corporate expenses and amortization as a barrier to volume growth; Curt confirmed total company AOI guidance unchanged at $2.1-2.3B, free cash flow improved to $1.1-1.7B driven by better working capital performance.

Calendar 2025 Q3

Can you give us maybe your assumptions for that piece of the guidance as to the high end, the low end, that would be great

Guidance ReliabilityMarginTranscript · FY2025 Q4 →
Show response

Donnie outlined USDA projecting ~1% chicken production increase, stable grains in line with futures, no runaway supply, and sustainable execution improvements in yields, capacity utilization, labor, and live performance. Noted branded fresh chicken up 7.8% and frozen value-added up 8.7% in Q4.

It looks like the finish was a little bit softer than expected. So first, what drove that with input costs, maybe poor beef pricing

ChallengingCost PressureMarginTranscript · FY2025 Q4 →
Show response

Devin explained miss was driven by rapid raw material cost rise with pricing lags not fully flowing through; noted full-year AOI up 1% despite headwinds; fill rates highest since 2013; expects FY2026 growth driven by innovation, operational excellence, and customer partnerships in both retail and foodservice.

Calendar 2025 Q2

you've significantly lowered the CapEx number versus what was previous out there. But at the same time, you also brought down the free cash flow guidance. Can you help us reconcile

ChallengingCapital AllocationTranscript · FY2025 Q3 →
Show response

Curt explained CapEx run rate was already tracking to lower end; free cash flow delta driven by working capital investment from top line growth and higher cattle costs flowing through inventory.

of these investments, are they still coming together as expected? Are you basically able to offset these costs right away

Capex InvestmentMarginTranscript · FY2025 Q3 →
Show response

Donnie confirmed $100M brand investment wrapping up in Q4; business running better than perhaps ever; sees momentum continuing through Q4, FY2026 and beyond. Devin noted branded chicken grew 10% and total value-added grew 8.8%. Kristina Lambert highlighted 20+ new items launched driving household penetration growth.

Calendar 2025 Q1

just wanted to understand a little bit better what you're seeing in terms of supply of cattle and the cost of that into your operations and how you think about the earlier signs maybe as to some of...

Supply ChainCost PressureTranscript · FY2025 Q2 →
Show response

Donnie noted seasonal Q2 demand softness is normal; Brady highlighted record cattle weights offsetting lower head counts, beef cow harvest down almost 18%, and heifers on feed down 4% YoY, signs aligning to a rebuild starting.

what have you done different and actually executed on to start to see the fruits and the benefits of all these investments that you had in years past to drive international

Revenue GrowthMarginTranscript · FY2025 Q2 →
Show response

Devin Cole credited operational fundamentals improvement and commercial growth execution; noted some one-time benefits in the quarter but expects favorable trend to continue, with caveat that back-half could be affected by macroeconomic consumer pressures.

Calendar 2024 Q4

could you help us maybe understand on a per segment basis the four major segments as we think about it

Guidance ReliabilityTranscript · FY2025 Q1 →
Show response

Curt explained prepared foods will be more back-half weighted, chicken strongest in Q1/Q3, and pork faces typical Q2 seasonal weather challenge.

what are your first take -- what is your first take as to the report and what -- how you think the conditions are for heifer retention potentially happening

Supply ChainCost PressureTranscript · FY2025 Q1 →
Show response

Brady detailed four leading indicators: improved pastures, record cattle prices supporting cow-calf profitability, cow harvest down 19%, and pasture land best use remaining cattle.

Calendar 2024 Q3

what are potential upside scenarios that would take you even beyond the current chicken outlook of call it maybe 1.2 billion at the higher end

Show response

Donnie and Wes provided extensive detail on operational improvements worth $500-700M annually independent of markets, plus branded growth drivers.

help us unpack a little bit the puts and takes within your outlook for '25 and maybe in a little bit more detail what gives you confidence of growth into next year

Guidance ReliabilityRevenue GrowthTranscript · FY2024 Q4 →
Show response

Donnie provided detailed segment-by-segment breakdown with five key takeaways, thorough answer with volume and mix color.

BGBunge Global12 questions · 6 reporting periods · 1 of 12 challenging
BG company page →

Calendar 2026 Q2

just wanted to understand what could drive you to the higher end of the range of the $1.5 billion to $1.7 billion.

Capex InvestmentCapital AllocationTranscript · FY2026 Q2 →
Show response

Neppl attributed the range to project completion and invoice timing and volunteered that the high end is the more likely landing spot.

Can you, kind of, dig maybe a little bit deeper on what's driving the current conditions to where they are?

Show response

Heckman covered refined oils and cocoa butter equivalents; Neppl added Avondale and Westhaven capacity, but neither sized the drag.

Calendar 2026 Q1

I wanted to understand a little bit more why the merchandising piece has been taken down considering all the disruption in the market?

Cost PressureDemandTranscript · FY2026 Q1 →
Show response

Neppl explained grain merchandising slowdown from ocean freight/bunker fuel costs. Heckman added tropicals pressured by lower food customer volumes, cocoa price declines hitting CBE margins, and tariff uncertainty keeping customers short-bought.

How should we think about the cadence? Because clearly, about 2 months ago, you talked about more like $0.80 to $0.90 for the first quarter

Guidance ReliabilityTranscript · FY2026 Q1 →
Show response

Neppl provided updated specific splits: 40-60 first/second half (previously 30-70) and 45-55 within second half. Clear and actionable for modeling.

Calendar 2025 Q4

how should we think about the current conditions, right? 2025 was a lot of uncertainty with trade

Show response

Heckman noted still early (6 months together), teams doing scenario analysis, developing new trade destinations from disruptions. Neppl added better YoY comps expected especially in first half against Bunge-only results.

how should we think about the return on investments here that $1 billion plus last year, probably another $1 billion this year

Show response

Neppl gave detailed project-by-project timeline: Moorestown commissioning now, Destrehan mid-year, West Sun early 2027. Not much contribution modeled for 2026. Additional $200-300M earmarked for other growth projects but not all approved.

Calendar 2025 Q3

Where do we stand now with that little over $0.5 billion that you've done in terms of what your initial consideration was for the buybacks when it came to the Viterra deal?

Capital AllocationTranscript · FY2025 Q3 →
Show response

Neppl provided specific figures: $2 billion total buybacks since Viterra announcement, $500 million from sugar divestment, $255 million remaining on Viterra program, well ahead of schedule.

help us understand a little bit better how you think about the opportunities, but also the risks of the larger footprint in Argentina

Geographic ExpansionMacroeconomicTranscript · FY2025 Q3 →
Show response

Heckman emphasized much more globally balanced footprint now, so Argentina disruption is less impactful and more opportunity. Benefits across soy crush, soft crush, export programs, and wheat origination feeding milling.

Calendar 2025 Q2

that seems like that was probably a little bit softer than what you initially expected for the quarter. And also, I mean, the tone for the guidance is a little weaker

ChallengingDemandRegulation PolicyPricingTranscript · FY2025 Q2 →
Show response

CEO cited lower biofuel-driven energy demand and tariff uncertainty causing customers to go very spot. Expects RSO improvement in H2 off Q2 levels.

as you look into the second half versus what you initially expected for the second half, has anything materially changed to the up or the downside

Guidance ReliabilityMarginTranscript · FY2025 Q2 →
Show response

CFO noted H2 skews 30/70 to Q3/Q4. Stronger processing in Q4 from US crush margins, offset by challenging merchandising and softer specialty oils. Already locked for most of Q3.

Calendar 2024 Q4

What do you expect from that in terms of contribution as to your, let's just assume it's still the same baseline

Capex InvestmentRevenue GrowthTranscript · FY2024 Q4 →
Show response

CFO confirmed growth projects on track to add ~$2.50 to baseline EPS by end of 2026 (from $8.50 to $11), with CJ Selecta as part of the plan. Projects largely on track.

Is that still more likely now to happen post-transaction close, or would you continue to buy shares even ahead of it

Capital AllocationTranscript · FY2024 Q4 →
Show response

CFO deferred specific timing but confirmed commitment to complete the remaining $800M in buybacks, opportunistically.

HRLHormel Foods11 questions · 6 reporting periods · 1 of 11 challenging
HRL company page →

Calendar 2026 Q3

in retail, we saw a rather significant volume decline. Can you maybe help us unpack that as well a little bit

Show response

John attributed about half the decline to exits, the rest to elasticity, while noting consumption growth on priority brands like Jennie-O and Applegate.

picking up on the guidance. If you could help us unpack maybe the drivers of, a, the top line guidance revision?

Guidance ReliabilityRevenue GrowthTranscript · FY2026 Q3 →
Show response

Jeff walked through the Q4 bridge, naming softer retail volumes and freight/fuel as the swing factors, with volume upside still possible.

Calendar 2026 Q2

you called out earlier in your remarks some structural weakness in certain retail brands and categories.

Competitive DynamicsDemandTranscript · FY2026 Q2 →
Show response

Ghingo detailed Planters (cashew trade-down) and Skippy (post-fire promo pullback) headwinds and the revenue-growth-management and digital actions underway.

Calendar 2025 Q4

where you are in terms of the journey of recovering on Planters of what you've lost in terms of where are you in shelf space, where are you on the profit side

Supply ChainMarginTranscript · FY2025 Q4 →
Show response

John reported Planters +12% dollar consumption, +6% volume, distribution +13%, base sales +10% in latest 13 weeks. Distribution recovery just about complete. Profitability hampered by mix shifts as consumers trade out of cashews due to pricing. Will lap cashew pricing in FY2026.

how should we think about that venture in Brazil? Is that still part of you want to be there, or is that something you would be open to put up for sale

Capital AllocationGeographic ExpansionTranscript · FY2025 Q4 →
Show response

John noted China continues to perform well as strategic priority. Brazil has been a drag on performance. Everything under portfolio review. Declined to commit to specific action on Brazil but implied it's being evaluated alongside all noncore holdings.

Calendar 2025 Q3

as you kind of come with fresh eyes, with fresh thoughts, you look at the business, what are you seeing? How do you feel about the company?

Competitive DynamicsCapital AllocationTranscript · FY2025 Q3 →
Show response

Jeff highlighted innovation leadership in bacon and pepperoni, healthy proteins (Jennie-O, Applegate), foodservice solutions, global brands (SPAM, Skippy), China growth, and non-meat protein (Planters, Skippy, Mexican). Emphasized mission of consistently driving top and bottom line growth.

what has changed so much versus, call it, late May, early June when the last time was when you updated the market? What has driven this revision?

ChallengingGuidance ReliabilityCost PressureTranscript · FY2025 Q3 →
Show response

John outlined four Q2 building blocks: turkey pricing, foodservice traffic recovery, Planters sequential recovery, T&M delivery. Three of four met expectations (turkey, T&M near high-end, broad-based growth). Three things went wrong: steep commodity run-up (biggest factor), foodservice traffic remained soft, and Planters profit recovery lagged top-line.

Calendar 2025 Q2

would you expect it to be, on a year-over-year basis, similar to last year? Or would you expect it to be similar to what we've seen, particularly in maybe 2Q?

Capital AllocationTranscript · FY2025 Q2 →
Show response

Jacinth noted they do not plan investment income given market unpredictability; actuals flow through as realized. Ben concluded to model zero.

how would you describe the situation of having regained some of that shelf space and some of those points of distribution that you lost last year after the outage at the facility? And what is your ...

Supply ChainRevenue GrowthTranscript · FY2025 Q2 →
Show response

John detailed sequential improvement continuing, year-over-year consumption turning positive in latter part of Q3 when lapping 2024 distribution losses. Three-part plan: stepped-up advertising, strong in-store promotions, innovation (flavored cashews, nut duos attracting younger consumers).

Calendar 2025 Q1

is that essentially the part where you're expecting to see the ramp-up as you need to get back into the different point of sales

Innovation & R&DCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Jim confirmed Q1 advertising pulled back on Planters during recovery. Sequential ramp-up expected with full year double-digit increase commitment.

What are your, like, internal assumptions of, like, these categories that already are growing

Revenue GrowthCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

John detailed three brand examples (Applegate premium, Spam value, Black Label innovation) showing resilience across price tiers. Flagship brands grew 3%+ volume and dollar; ex-Planters over 5%.

ADMArcher Daniels Midland9 questions · 6 reporting periods · 2 of 9 challenging
ADM company page →

Calendar 2026 Q2

how fast do you think customers of yours will have to launch new products and basically apply these more natural colors

Product LaunchDemandTranscript · FY2026 Q2 →
Show response

Luciano framed natural colors as a $1 billion addressable market yielding $80 million to $100 million of nutrition operating profit over the coming years.

just wanted to understand what is like the scenario to get it closer to that 5.5, 5.60?

Guidance ReliabilityMarginTranscript · FY2026 Q2 →
Show response

Luciano bridged to the high end via continued execution, a favorable biofuels backdrop and China soybean buying, with Q3 crush 90% locked and Q4 about 30% locked.

Calendar 2026 Q1

what factors you're kind of like seeing that could drive you to the higher end of that new guidance

Guidance ReliabilityMacroeconomicTranscript · FY2026 Q1 →
Show response

Luciano walked through each segment: AS&O expects mark-to-market reversals and China normalization, Carb Solutions expects continued ethanol strength, Nutrition growth intact via flavors.

are there any specific measures that you can take to kind of like maybe stop the bleeding a little too harsh

ChallengingDemandInnovation & R&DTranscript · FY2026 Q1 →
Show response

Luciano noted ongoing diversification into industrial applications (personal care, fabric softeners) but acknowledged these markets are smaller and the shift is slow.

Calendar 2025 Q4

as we move into '26, maybe can you give us an update on where you stand with, like, gaining these customers back on the fulfillment, everything that you first lost on Decatur East that you now need...

DemandRevenue GrowthTranscript · FY2025 Q4 →
Show response

Management outlined Decatur East recovery is underway but gradual, plant stabilization first, then productivity optimization, then customer win-back. Flavors OP was up ~60% in Q4, biotics up even more. Europe was soft in Q4 but recovered in January 2026.

Calendar 2025 Q3

Monish, just real quick on those insurance gains, you said half and half to come from. So that half that's kept us that's somehow then reflected

Show response

CFO confirmed Q4 insurance proceeds of approximately $35 million split half captive, half third-party, versus $135 million mostly third-party funded in prior year Q4.

can you help us reconcile a little bit the sequential decline in the third quarter for crush versus what you had in the second quarter

MarginGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Management explained board crush swung from $2.25 to $1.20 and back to $1.50 due to SRE uncertainty and trade deal speculation, with Q4 expected flat to slightly up vs Q3.

Calendar 2025 Q2

with Decatur East coming back, as we look into this and kind of like have like an LTM run rate, kind of call it about $400 million operating income

MarginSupply ChainTranscript · FY2025 Q2 →
Show response

Management estimated approximately $100 million in Specialty Ingredients headwinds will be removed in 2026 once Decatur East reaches stable full production.

Calendar 2024 Q4

Q1 is very tough comp and you already indicated that to be 50% down. But then in order to get to just slightly below 25 levels as your guidance indicates

ChallengingMarginGuidance ReliabilityTranscript · FY2024 Q4 →
Show response

Management pointed to manufacturing improvements, destination marketing growth, and direct farming procurement gains to bridge the gap from a weak Q1.

CFCF Industries8 questions · 6 reporting periods · 1 of 8 challenging
CF company page →

Calendar 2026 Q2

are you seeing any impacts on the extra Texas capacity this year, like Gulf Coast ammonia, Woodside?

Supply ChainCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Frost said new Texas tons have been absorbed into the global market, and with Yara buying the Gulf Coast plant much of that product will likely go to Europe.

Calendar 2026 Q1

how do those actions impact global pricing and the benefits you might have, particularly in North America? Second, you mentioned shutdowns of facilities that might not be damaged. Assuming the conf...

Competitive DynamicsSupply ChainTranscript · FY2026 Q1 →
Show response

Bert said China needed to export all of its 5M tons from 2025 and more to balance but that is not possible given Gulf disruptions. Expected Chinese exports June through October. North Africa supplies at $800-850/mt. Chris detailed restart timeline: 1-3 months for preserved shutdowns depending on maintenance and parts, plus months for vessel repositioning. Quantified 31 ammonia plants in Middle East impacted, 49 in South Asia curtailed, and 20-21 Russian plants affected by drone activity.

Calendar 2025 Q4

how should we think about, a, the market and b, some of these drivers over more EBITDA generation, the tax credits, et cetera, as we move through 2026, considering the [ $200 ] million miss on Yazo...

Show response

Bert detailed multiple demand drivers: USDA projecting 93M+ corn acres, India tender opened, European imports rising on $11 gas and CBAM, South America strong. Chris added 2026 first half looks very strong with full year CCS at Donaldsonville expected to sequester just under 1.5M tons versus 700K in 2025. Both positioned 2026 as bridging to even tighter market when Blue Point comes online.

Calendar 2025 Q3

the blue ammonia that you're getting out of Donaldsonville, can you give us a little sense of magnitude as to the premium that you're getting here with your customers?

PricingInnovation & R&DTranscript · FY2025 Q3 →
Show response

Bert quantified premium at $20-$25 per ton expected to grow with demand. Tony noted premium was never part of original CCS economics, adding roughly $40-$50M of EBITDA on top of the $100M from 45Q credits, representing 50% more than initially justified.

I just want to understand the current market conditions obviously still seem to a degree, stretched, right, with the European gas price somewhat elevated versus what maybe mid-cycle in the past was

MarginMacroeconomicTranscript · FY2025 Q3 →
Show response

Greg noted mid-cycle assumed $3.50 gas and $3.85 urea with actuals running better on both. Tony confirmed full year 2025 expected well above mid-cycle. Chris added the $3B 2030 growth target is identified and in motion, not speculative pipeline items.

Calendar 2025 Q2

it feels like the gas price came down, but at the same time, gross margin was actually significantly worse on a sequential basis

ChallengingMarginCost PressureTranscript · FY2025 Q2 →
Show response

Greg and Chris attributed margin compression to unplanned outages at two facilities and elevated logistics costs from tight inventory product redistribution. Bert noted Q3 will have heavier turnaround activity with a couple hundred thousand fewer tons of gross ammonia production.

Calendar 2025 Q1

you saw news that the Chinese government setting an export window from May through September, for urea as it relates to the potential quota

Competitive DynamicsSupply ChainTranscript · FY2025 Q1 →
Show response

Tony said 3-4 million tons from China is consistent with expectations and needed by the tight global market. Cautioned that rising domestic Chinese urea prices could cause export license rescission as occurred previously.

the European Union, is considering a potential embargo actually on Russian gas. Have you seen or heard any news

Show response

Tony noted the European plan to eliminate Russian gas by 2027 is a European policy decision largely outside US influence. Characterized both Washington and European policy environments as opaque.

CTVACorteva3 questions · 3 reporting periods · 0 of 3 challenging
CTVA company page →

Calendar 2026 Q2

wanted to dig a little bit deeper into some of the productivity savings and just lower costs that you highlighted?

Cost PressureMarginTranscript · FY2026 Q2 →
Show response

Johnson and Magro pointed to continued productivity in both businesses and dis-synergies cut from a $100M estimate toward $25M via separation efficiency.

Calendar 2026 Q1

What are the considerations you are putting into place as it relates to the level of capitalization or leverage

Capital AllocationM&ATranscript · FY2026 Q1 →
Show response

David confirmed both companies targeting investment grade, with pension staying with new Corteva and the $1.5B discretionary contribution ensuring appropriate funding levels.

Calendar 2025 Q3

how would you see the opportunities and the likelihood of you being as well active here on potentially M&A

Show response

Chuck said independent CP company will likely accelerate biologicals M&A, commercial and R&D collaborations. Biologicals industry is fragmented with smaller companies doing innovative work.

Show 1 more company
MOSMosaic Company (The)3 questions · 3 reporting periods · 1 of 3 challenging
MOS company page →

Calendar 2026 Q2

you expect profitability to be down in the third quarter compared to the second quarter

Show response

Bodine said Q3 volumes rise seasonally but curtailed Brazil production caps supply, muting EBITDA. Luciano sees the production business near breakeven on coproducts, with distribution plus early Biosciences keeping Brazil positive but below Q2's $60 million.

Calendar 2025 Q3

help us understand what is taking it back to square one so to speak

ChallengingMarginRevenue GrowthTranscript · FY2025 Q3 →
Show response

Bodine pushed back on 'square one' framing, Q4 expected above prior year despite being seasonally weakest. Luciano broke down ~$70M decline from production business due to lower-margin product mix (Brazilian market buying more SSP), ~$20M decline in co-product sales (seasonal), and loss of bad debt recovery tailwind. Credit challenges affecting small farmer segment, driving customer base consolidation.

Calendar 2024 Q4

I was just wondering about the cost you've talked about that you've taken out, and obviously, you expect some of it to come back from the losses in the third quarter with AgroGalaxy

Cost PressureMarginTranscript · FY2024 Q4 →
Show response

Ciani pointed to audited non-GAAP costs in Brazilian reais as a ceiling for future modeling. Expressed high confidence in AgroGalaxy insurance recovery within 2025 but could not specify the quarter.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
TSN Tyson Foods1513%2 of 15 questions
BG Bunge Global128%1 of 12 questions
HRL Hormel Foods119%1 of 11 questions
ADM Archer Daniels Midland922%2 of 9 questions
CF CF Industries813%1 of 8 questions
CTVA Corteva30%none of 3 questions
MOS Mosaic Company (The)333%1 of 3 questions
  • TSN
    Tyson Foods · 15 questions
    13%2 of 15 questions
  • BG
    Bunge Global · 12 questions
    8%1 of 12 questions
  • HRL
    Hormel Foods · 11 questions
    9%1 of 11 questions
  • ADM
    Archer Daniels Midland · 9 questions
    22%2 of 9 questions
  • CF
    CF Industries · 8 questions
    13%1 of 8 questions
  • CTVA
    Corteva · 3 questions
    0%none of 3 questions
  • MOS
    Mosaic Company (The) · 3 questions
    33%1 of 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q320%none of 2 questions1
2024 Q4617%1 of 6 questions4
2025 Q160%none of 6 questions3
2025 Q2838%3 of 8 questions5
2025 Q31225%3 of 12 questions7
2025 Q480%none of 8 questions5
2026 Q1714%1 of 7 questions5
2026 Q2100%none of 10 questions7
2026 Q320%none of 2 questions1
  1. 2024 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company
  2. 2024 Q46 questions · challenge rate 17% (1 of 6 questions) · 4 companies
  3. 2025 Q16 questions · challenge rate 0% (none of 6 questions) · 3 companies
  4. 2025 Q28 questions · challenge rate 38% (3 of 8 questions) · 5 companies
  5. 2025 Q312 questions · challenge rate 25% (3 of 12 questions) · 7 companies
  6. 2025 Q48 questions · challenge rate 0% (none of 8 questions) · 5 companies
  7. 2026 Q17 questions · challenge rate 14% (1 of 7 questions) · 5 companies
  8. 2026 Q210 questions · challenge rate 0% (none of 10 questions) · 7 companies
  9. 2026 Q32 questions · challenge rate 0% (none of 2 questions) · 1 company

Topics

Topics tagged on this analyst’s questions.

  • Margin22
  • Guidance Reliability13
  • Demand12
  • Cost Pressure10
  • Capital Allocation9
  • Revenue Growth8
  • Supply Chain8
  • Competitive Dynamics8
  • Pricing4
  • Capex Investment4
Show all 16 topics
  • Innovation & R&D4
  • Macroeconomic4
  • M&A3
  • Product Launch2
  • Geographic Expansion2
  • Regulation Policy1